An FDA-approved medication called glucarpidase could serve as an antidote to kidney toxicity in patients receiving the chemotherapy drug methotrexate...
Vous n'êtes pas connecté
Researchers at the Medical University of South Carolina have discovered that an FDA-approved drug, N-acetylcysteine (NAC), could help reduce pain for patients recovering from surgery. This exciting finding offers a new way to manage pain with fewer opioids, potentially improving patient safety and reducing the risk of addiction. NAC is a medication commonly used to […]
An FDA-approved medication called glucarpidase could serve as an antidote to kidney toxicity in patients receiving the chemotherapy drug methotrexate...
The United States Food and Drug Administration (FDA) has submitted a proposal to make cigarettes less addictive by lowering their nicotine content....
The United States Food and Drug Administration (FDA) has submitted a proposal to make cigarettes less addictive by lowering their nicotine content....
THURSDAY, Jan. 16, 2025 -- A rather historic U.S. Food and Drug Administration (FDA) proposal aims to make cigarettes and other tobacco products far...
Johnson & Johnson medication Spravato, a ketamine-based nasal spray, was approved Tuesday by the Food and Drug Administration for use as a sole...
A recent study published in JAMA Surgery reveals a surprising connection between surgeon stress at the start of a procedure and patient outcomes....
Oesophageal squamous cell carcinoma (ESCC) is a severe health threat, being a predominant subtype of oesophageal cancer and contributing significantly...
Audience: Patient, Caregiver, Health Care Professional, Pharmacy, Neurology ISSUE: The FDA is warning about the risk of a rare but serious allergic...
THURSDAY, Jan. 9, 2025 -- Over-the-counter (OTC) drugs acetaminophen and ibuprofen are better at managing dental pain than opioids. People who had...
Chronic low back pain is a major cause of disability worldwide, often leaving patients frustrated when treatments like medication fail to provide...